Sigyn Therapeutics (SIGY) Convertible Debt (2016 - 2020)
Sigyn Therapeutics (SIGY) posted Convertible Debt of $1.8 million for Q3 2020, little changed sequentially from $1.8 million in Q2 2020, and up 1.41% YoY from $1.8 million in Q4 2019.
Sigyn Therapeutics (SIGY) Convertible Debt (2016 - 2020) Analysis & Trends
Sigyn Therapeutics has reported Convertible Debt for 5 years, with the latest figure at $1.8 million in Q3 2020.
- Quarterly Convertible Debt rose 1.41% year-over-year to $1.8 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $1.8 million (up 1.41% YoY) and the FY2019 annual result came in at $1.8 million, up 4.04% from the prior year.
- Convertible Debt steadied at $1.8 million in Q3 2020 per SIGY's latest filing, from $1.8 million in the prior quarter.
- Over five years, Convertible Debt peaked at $1.8 million in Q4 2019 and troughed at $17505.0 in Q2 2017.
- A 5-year average of $1.3 million and a median of $1.7 million in 2018 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2017 and 2020: Convertible Debt surged 4570.25% in 2017, then gained 1.41% in 2020.
- Over 5 years, Convertible Debt stood at $30780.0 in 2016, then soared by 4570.25% to $1.4 million in 2017, then advanced by 20.45% to $1.7 million in 2018, then rose by 4.04% to $1.8 million in 2019, then decreased by 0.28% to $1.8 million in 2020.
- According to Business Quant data, Convertible Debt over the past three periods registered $1.8 million, $1.8 million, and $1.8 million for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 1.80 Mn |
| Jun 30, 2020 | 1.80 Mn |
| Mar 31, 2020 | 1.80 Mn |
| Dec 31, 2019 | 1.80 Mn |
| Sep 30, 2019 | 1.77 Mn |
| Jun 30, 2019 | 1.73 Mn |
| Mar 31, 2019 | 1.73 Mn |
| Dec 31, 2018 | 1.73 Mn |
| Mar 31, 2018 | 287,502.00 |
| Dec 31, 2017 | 1.44 Mn |
| Jun 30, 2017 | 17,505.00 |
| Dec 31, 2016 | 30,780.00 |